“The Treaty of Nations: Claiming Select Nation Status in the Global Covenant of Reproducibility”
- Richard M Fleming, PhD, MD, JD
- Dec 15, 2025
- 6 min read
Updated: Dec 16, 2025
“Science · Sovereignty · Fellowship — The Founding Charter of Measurable Medicine”
In the fall of 2025, we transmitted our initial letters of introduction, announcing the forthcoming release of FMTVDM FRONTIER and the designation of up to three Select Nation Status (SNS) countries. With gratitude for your engagement and foresight, we now provide this follow‑up communication to reaffirm the unique advantages available to your nation and to outline the next steps toward sovereign adoption.
Each country and region of the world carries its own distinct rationale for becoming one of the first three SNS nations. For Asia, the urgency lies in transforming rising healthcare expenditures into measurable savings; for Africa, the opportunity is to convert systemic underfunding into equitable, reproducible care; for the Mediterranean, the challenge is to unify fragmented systems under sovereign calibration; for Europe, saturated spending demands a shift toward efficiency and measurable medicine; for South America, reactive systems must evolve into proactive, quantified diagnostics; for the Pacific Islands, vulnerable infrastructures can be fortified through reproducible sovereignty; for the Americas, unsustainable growth requires measurable containment; and globally, escalating costs call for a covenant of reproducibility. Each pathway is unique, yet all converge upon the same sovereign truth: nations that lead through FMTVDM FRONTIER quantification will define the future of medicine, diplomacy, and public trust.
It is with profound respect and anticipation that we transmit this letter, marking a significant milestone in the advancement of medical science, ethical governance, and sovereign collaboration.
Completion of Foundational Works
FMTVDM FRONTIER Textbooks – Three Volumes
Credentialing Manuals: CCC, CFP, and DF‑FMTVDM
Standard Operating Procedures (SOP) Manual
Ethics Manual
FMTVDM Scientific Textbook – Four Volumes
Together, these works establish a closed‑loop national framework for scientific quantification, credentialing authority, ethical governance, and operational control—enabling participating nations to standardize care, train domestic expertise, and retain scientific autonomy.
Transmission of Policy Brief
Enclosed is the FMTVDM FRONTIER Policy Brief v2.1 (November 21, 2025), issued by the Consortium Board. It provides:
Executive Overview: Scientific canon, credentialing authority, diplomatic framework, public health impact, and policy options.
Scientific Foundation: Absolute quantification of Regional Blood Flow (RBF) and Functional Metabolic Change (FMC).
Public Health Impact: Earlier diagnosis, therapy monitoring, avoidance of unnecessary interventions, reduced expenditures, improved equity.
Implementation Architecture: Four‑phase rollout—recognition, accreditation, certification, integration.
Governance and Oversight: National registries, credentialed Fellows, sovereign oversight bodies.
International Alignment: Compatibility with WHO, IAEA, SNMMI, ASNC, EANM.
Legal and Licensing Framework: Patent US9566037B2, sovereign licensing agreements, IP safeguards.
Policy Recommendation: Formal recognition of FMTVDM® as the national standard.
National Advantages and Strategic Leadership
Global Scientific Leadership: Nations become reference authorities in quantitative nuclear medicine.
Healthcare Cost Containment: Escalating costs—Asia’s rising expenditures, Africa’s underfunding, Europe’s saturation, America’s unsustainable growth—can be reversed by reproducible quantification. Ministries save billions to trillions in U.S. dollars over a decade by reducing unnecessary imaging, procedures, and therapies.
Data and Decision Sovereignty: National control of standards protects integrity and autonomy.
Domestic Capacity Building: Training and credentialing cultivate homegrown expertise.
International Prestige and Influence: SNS designation elevates nations as leaders in evidence‑based medicine.
Digital Resources
FMTVDM FRONTIER: www.fmtvdm.com
FMTVDM Blog: www.fmtvdm.com/blog
These platforms document validation, credentialing pathways, and updates supporting readiness for Spring 2026 integration.
Ongoing Coordination and Engagement
As preparations advance, we welcome continued dialogue regarding recognition, accreditation, certification, and national implementation planning. Together, we will advance a new frontier of quantitative medicine, sovereign stewardship, and international fellowship, guided by: Science · Sovereignty · Fellowship
Call to Action
We now invite your nation to take decisive steps toward becoming one of the first three Select Nation Status (SNS) countries. This is not merely an opportunity to adopt a new diagnostic and theranostic standard—it is a chance to secure sovereign global leadership, contain escalating healthcare costs, and inscribe your nation’s name into the global covenant of reproducibility. By acting now, your ministry ensures that your country is recognized as a founding exemplar of measurable medicine, shaping international standards and safeguarding public trust for generations to come. The path to SNS designation is open; the moment to claim it is now.
FMTVDM FRONTIER Sovereign Transformation:
Nations Converting Waste into Measurable Progress
Asia: Rising Costs into Measurable Progress
Asia faces double‑digit annual medical cost increases, with countries like Indonesia projected at 17.8% growth and the Philippines at 16% (https://www.fmtvdm.com/post/asia-s-healthcare-crossroads-transforming-rising-costs-into-measurable-progress-with-fmtvdm-fro). Aging populations and chronic disease burdens make current spending unsustainable. FMTVDM FRONTIER reduces unnecessary imaging and therapies, redirecting billions toward prevention and innovation. By quantifying diagnostics, ministries can contain runaway costs and establish sovereign independence, positioning themselves as global reference authorities.
Africa: Underfunding into Measurable Progress
Across Africa, healthcare systems are constrained by declining external aid (70% drop in ODA between 2021–2025) and spiraling debt obligations (https://www.fmtvdm.com/post/africa-s-healthcare-inflection-point-turning-systemic-underfunding-into-measurable-progress-with). This underfunding forces reliance on reactive care and external consultants. FMTVDM FRONTIER empowers ministries to maximize scarce resources by eliminating wasteful interventions and ensuring reproducible diagnostics. Sovereign credentialing builds domestic capacity, reducing dependency and unlocking sustainable health gains at lower long‑term cost.
Mediterranean: Fragmented Systems into Measurable
Medicine
Despite strong medical traditions, Mediterranean nations lose billions annually to fragmented protocols, siloed data, and bureaucratic inefficiency (https://www.fmtvdm.com/post/the-mediterranean-s-healthcare-dilemma-converting-fragmented-systems-into-measurable-medicine-wi). FMTVDM FRONTIER unifies disparate systems under calibrated reproducibility, reducing duplication and inefficiency. By harmonizing care, nations achieve measurable savings while elevating sovereignty in health governance, converting fragmentation into a unified, cost‑efficient covenant of measurable medicine.
Europe: Saturated Spending into Measurable Medicine
Europe spends €1.7 trillion annually on healthcare (10% of GDP), yet outcomes remain fragmented and reactive
(https://www.fmtvdm.com/post/europe-s-healthcare-crossroads-from-saturated-spending-to-measurable-medicine-with-fmtvdm-fro). Saturated spending yields diminishing returns, with aging populations driving costs higher. FMTVDM FRONTIER shifts systems from volume to value, eliminating unnecessary procedures and redirecting funds toward innovation. SNS designation positions nations as leaders in measurable medicine, ensuring sustainability and sovereign efficiency.
South America: Reactive Systems into Measurable
Medicine
South America’s systems remain reactive, with late‑stage interventions consuming vast resources (https://www.fmtvdm.com/post/south-america-s-healthcare-challenge-from-reactive-systems-to-measurable-medicine-with-fmtvdm-f). Crisis‑driven spending undermines prevention and efficiency. FMTVDM FRONTIER enables proactive diagnostics, reducing costly late‑stage treatments and empowering governments to deliver reproducible, accountable care. Sovereign quantification shifts nations from reactive spending to measurable savings, strengthening both economic stability and leadership.
Pacific Islands: Vulnerable Systems into Measurable
Medicine
Pacific Island nations face geographic isolation, limited resources, and vulnerability to external shocks
(https://www.fmtvdm.com/post/pacific-island-countries-from-vulnerable-systems-to-measurable-medicine-with-fmtvdm-frontier). Current systems are built for response, not resilience, leading to costly dependence on external vendors. FMTVDM FRONTIER transforms vulnerable infrastructures into reproducible medicine, delivering absolute imaging results across borders. Sovereign adoption ensures measurable savings, fortifies resilience, and secures national health sovereignty.
Americas: Unsustainable Growth into Measurable
Medicine
The United States alone is projected to spend $7.6 trillion annually by 2035 under current models (https://www.fmtvdm.com/post/america-s-healthcare-cost-crisis-from-unsustainable-growth-to-measurable-medicine-with-fmtvdm). Spiraling costs threaten solvency, with billions wasted on unnecessary procedures. FMTVDM FRONTIER introduces reproducible quantification, reversing unsustainable growth and reclaiming wasted expenditures. Sovereign credentialing ensures measurable medicine, restoring sustainability and reinforcing national leadership in global healthcare.
Global: Escalating Costs into Measurable Medicine
Worldwide, healthcare costs are rising at 10–12% annually, consuming trillions without proportional gains
(https://www.fmtvdm.com/post/global-healthcare-at-a-crossroads-from-escalating-costs-to-measurable-medicine-with-fmtvdm-fron). Reactive models chase disease rather than prevent it. FMTVDM FRONTIER provides reproducible quantification, enabling nations to measure, manage, and intervene with precision. SNS countries will lead the transformation, turning escalating costs into measurable savings and defining reproducibility as the new global covenant.
Ceremonial Declaration
This transmission is not simply correspondence—it is a sovereign invitation. The designation of Select Nation Status (SNS) will be conferred upon only three nations at the time of the global launch in Spring 2026. Those who act decisively will secure their place as founding exemplars of reproducible medicine, inscribing their sovereignty into the global covenant of measurable healthcare.
Final Call to Action
We now summon nations and ministries to rise and inscribe their names into the covenant of reproducibility. By affirming Select Nation Status (SNS) designation, those who act decisively will not merely safeguard their healthcare systems against escalating costs — they will enthrone themselves as sovereign leaders in science, diplomacy, and public trust.
This is a rare moment in history: a founding opportunity to define measurable medicine for generations. The benefits are enduring, the covenant unbreakable, and the call unmistakable.
The path is open. The charter awaits. The moment to claim sovereign leadership is now.
Comments